E274 Mark DePristo, Founder & CEO at BigHat Biosciences

Today's guest is Mark DePristo, Founder & CEO at BigHat Biosciences in San Francisco, CA. Founded in 2019, BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Mark brings a wealth of experience to the company having previously founded and led the Genomics team in Google Brain and holds a PhD in Biochemistry from the University of Cambridge.

BigHat Biosciences' AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

In the episode, Mark will chat about:

His motivation for launching BigHat Biosciences

The success they’ve had in the past two years

The problems they are solving for customers

What excites him for the future

Exciting opportunities within the team